Statutory regulation of subsidized pharmaceutical provision in Russian Federation

Abstract

At present in the Russian Federation (the RF), an organized system of pharmaceutical provision of benefit-entitled citizens is used. With this, statutory regulation is under continuous improvement through adoption of new regulatory acts and amendments to already existing ones [1]. The basis of this process is equal opportunities and rights of all individuals for free provision with medical drugs. Nevertheless, there exist benefit-entitled categories of citizens for whom additional approaches to organization of pharmaceutical provision were adopted. Aim. Analysis of statutory regulation applicable to the existing benefit-entitled citizens. Conclusion . The established normative framework regulating pharmaceutical provision of benefit-entitled citizens both on the federal and regional levels, permits patients to receive the necessary life-saving medicinal therapy. With this, an obligatory condition for receiving such  assistance is presence of a certain diagnosis or a certain social status. Far not all patients are included into the list of benefit-entitled citizens. Hence, the existing statutory regulation of healthcare requires further improvement.